Khalil Choucair, Assistant Professor of Oncology at Wayne State University School of Medicine, shared a post on LinkedIn:
“Our latest study is now published in JCO Global Oncology.
Using one of the largest multinational registry of ALK-positive NSCLC, we report real-World treatment patterns, sequencing strategies, and long-term outcomes across 71 countries.
This work reflects the contributions of patients and collaborators around the world. Quality-of-life analyses from this cohort are coming next.”
Title: Longitudinal Treatment Outcomes in Patients With Anaplastic Lymphoma Kinase-Rearranged Non–Small Cell Lung Cancer: Results From a Multinational Registry-Based Study in a Predominantly Western Population
Authors: Khalil Choucair, Hayat Bazzi, Faten Abda, Farah Harb, Yasmin Snounu, Vy Ong, Wei Chen, Colin Barton, Hirva Mamdani, Shirish Gadgeel, Morhaf Al Achkar
Read the Full Article.
You can also read:
When ADC Toxicity Is Not the Same for Everyone: A Sex-Based Signal in NSCLC
